Study of Vorinostat Plus Melphalan and Prednisone (Zmp) in Advanced, Refractory Multiple Myeloma Patients

NCT00857324 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
18
Enrollment
OTHER
Sponsor class

Stopped The Phase I of the study was completed, but Phase 2 has not been activated

Conditions

Interventions

Sponsor

Tiziana Marangon